Unichem Laboratories Limited — Others, 04-08-2025: Shareholders meeting

Unichem Laboratories held its 62nd Annual General Meeting virtually. Shareholders adopted the audited standalone and consolidated annual financial results for the year ended March 31, 2025, and re-appointed Dr. Prakash Mody as a director. Key approvals included material related party transactions with holding company Ipca Laboratories and wholly-owned subsidiary Unichem Pharmaceuticals (USA) Inc. Members also approved the appointment of Secretarial Auditors and ratified the Cost Auditors' remuneration. The meeting covered company performance updates and addressed shareholder queries. E-voting results will be shared with exchanges soon.